CEO and President
Thu, Apr 4, 2024
Apr 4
829 shares @ $2.62
Decreased holdings by -1.70%
29th largest trade (out of 107)
Positive 90D History
Trade made by an officer
10b5-1 scheduled trade
63% win rate · +6.9% median edge vs SPY (16 trades, 90-day · small sample)
Insider trade was 94% below market price
Price 43% below 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+12.20%
3M—
6M—
1Y—